Korro Bio (KRRO) Enterprise Value (2018 - 2026)
Korro Bio (KRRO) posted Enterprise Value of -$114.0 million for Q1 2026, down 51.64% on a QoQ basis from -$75.2 million in Q4 2025, and up 0.86% year-over-year from -$113.0 million in Q1 2025.
Korro Bio (KRRO) Enterprise Value (2018 - 2026) Analysis & Trends
Korro Bio's Enterprise Value history runs 9 years deep, the most recent figure standing at -$114.0 million for Q1 2026.
- Quarterly Enterprise Value rose 0.86% year-over-year to -$114.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$114.0 million (up 0.86% YoY) and the FY2025 annual result came in at -$75.2 million, up 40.4% from the prior year.
- Enterprise Value was -$114.0 million for Q1 2026 at Korro Bio, down from -$75.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$36.9 million in Q4 2022 and bottomed at -$169.8 million in Q4 2023.
- A 5-year average of -$102.7 million and a median of -$111.0 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 71.74% — and 2023, when it plunged 359.62%.
- Korro Bio's Enterprise Value stood at -$36.9 million in 2022, then slumped by 359.62% to -$169.8 million in 2023, then climbed by 25.72% to -$126.1 million in 2024, then surged by 40.4% to -$75.2 million in 2025, then slumped by 51.64% to -$114.0 million in 2026.
- Business Quant data shows KRRO's Enterprise Value at -$114.0 million in Q1 2026, -$75.2 million in Q4 2025, and -$92.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -1.91 Bn |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | -113.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -113.97 Mn |
| Dec 31, 2025 | -75.16 Mn |
| Sep 30, 2025 | -92.48 Mn |
| Jun 30, 2025 | -96.36 Mn |
| Mar 31, 2025 | -114.95 Mn |
| Dec 31, 2024 | -126.10 Mn |
| Sep 30, 2024 | -137.00 Mn |
| Jun 30, 2024 | -157.43 Mn |
| Mar 31, 2024 | -142.35 Mn |
| Dec 31, 2023 | -169.75 Mn |
| Sep 30, 2023 | -41.72 Mn |
| Jun 30, 2023 | -46.48 Mn |
| Mar 31, 2023 | -66.65 Mn |
| Dec 31, 2022 | -36.93 Mn |
| Sep 30, 2022 | -99.35 Mn |
| Jun 30, 2022 | -111.02 Mn |
| Mar 31, 2022 | -117.36 Mn |
| Dec 31, 2021 | -130.71 Mn |
| Sep 30, 2021 | -148.07 Mn |
| Jun 30, 2021 | -168.89 Mn |